Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

US Patent 11207361 · Granted Dec 28, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AAV with unique capsid protein VP1 and methods of using for treatment2022
Methods for the diagnosis and treatment of Sjögren's syndrome2020
Detection of hepatitis delta virus (HDV) for the diagnosis and treatment of Sjög2020
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from2019
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from2019
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from2019
AAV mediated aquaporin gene transfer to treat Sjogren's syndrome2019
Adeno-associated vectors for enhanced transduction and reduced immunogenicity2018
Methods for the diagnosis and treatment of sjögren's syndrome2017
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from2016
AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from2016
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associa2016